Shares in Intercell AG rose by more than 8.5 percent Monday on news that the company's lead product, a vaccine against Japanese Encephalitis virus (JEV), received a positive opinion from the Committee on Human Medicinal Products, of the European Medicines Agency. (BioWorld International) Read More
No Abstract BioWorld International CorrespondentPARIS - Domain Therapeutics SA, which was called Faust Pharmaceuticals SA until early December, has raised €2.1 million (US$2.8 million) to finance its drug discovery activities, which are focused on the identification of allosteric modulators of G Protein-Coupled Receptors (GPCRs). Read More
